|
1
|
Xing M: BRAF mutation in thyroid cancer.
Endocr Relat Cancer. 12:245–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fukushima T, Suzuki S, Mashiko M, Ohtake
T, Endo Y, Takebayashi Y, Sekikawa K, Hagiwara K and Takenoshita S:
BRAF mutations in papillary carcinomas of the thyroid. Oncogene.
22:6455–6457. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu X, Quiros RM, Gattuso P, Ain KB and
Prinz RA: High prevalence of BRAF gene mutation in papillary
thyroid carcinomas and thyroid tumor cell lines. Cancer Res.
63:4561–4567. 2003.PubMed/NCBI
|
|
4
|
Ikawa S, Fukui M, Ueyama Y, Tamaoki N,
Yamamoto T and Toyoshima K: B-raf, a new member of the raf family,
is activated by DNA rearrangement. Mol Cell Biol. 8:2651–2654.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Davies H, Bignell GR, Cox C, Stephens P,
Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W,
et al: Mutations of the BRAF gene in human cancer. Nature.
417:949–954. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cohen Y, Xing M, Mambo E, Guo Z, Wu G,
Trink B, Beller U, Westra WH, Ladenson PW and Sidransky D: BRAF
mutation in papillary thyroid carcinoma. J Natl Cancer Inst.
95:625–627. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fugazzola L, Mannavola D, Cirello V,
Vannucchi G, Muzza M, Vicentini L and Beck-Peccoz P: BRAF mutations
in an Italian cohort of thyroid cancers. Clin Endocrinol (Oxf).
61:239–243. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim KH, Kang DW, Kim SH, Seong IO and Kang
DY: Mutations of the BRAF gene in papillary thyroid carcinoma in a
Korean population. Yonsei Med J. 45:818–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sithanandam G, Druck T, Cannizzaro LA,
Leuzzi G, Huebner K and Rapp UR: B-raf and a B-raf pseudogene are
located on 7q in man. Oncogene. 7:795–799. 1992.PubMed/NCBI
|
|
10
|
Mercer KE and Pritchard CA: Raf proteins
and cancer: B-Raf is identified as a mutational target. Biochim
Biophys Acta. 1653:25–40. 2003.PubMed/NCBI
|
|
11
|
Soares P, Trovisco V, Rocha AS, Lima J,
Castro P, Preto A, Máximo V, Botelho T, Seruca R and
Sobrinho-Simões M: BRAF mutations and RET/PTC rearrangements are
alternative events in the etiopathogenesis of PTC. Oncogene.
22:4578–4580. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nikiforova MN, Ciampi R, Salvatore G,
Santoro M, Gandhi M, Knauf JA, Thomas GA, Jeremiah S, Bogdanova TI,
Tronko MD, et al: Low prevalence of BRAF mutations in
radiation-induced thyroid tumors in contrast to sporadic papillary
carcinomas. Cancer Lett. 209:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lima J, Trovisco V, Soares P, Máximo V,
Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M,
Abrosimov A, et al: Reply to: Low prevalence of BRAF mutations in
radiation-induced thyroid tumors in contrast to sporadic papillary
carcinomas. Cancer Lett. 230:149–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P,
Zhang Y, Shan Z, Teng W and Xing M: Association of high iodine
intake with the T1799A BRAF mutation in papillary thyroid cancer. J
Clin Endocrinol Metab. 94:1612–1617. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watanabe R, Hayashi Y, Sassa M, Kikumori
T, Imai T, Kiuchi T and Murata Y: Possible involvement of BRAF
V600E in altered gene expression in papillary thyroid cancer.
Endocr J. 56:407–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Lee ES and Kim YS:
Clinicopathologic significance of BRAF V600E mutation in papillary
carcinomas of the thyroid: A meta-analysis. Cancer. 110:38–46.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nikiforova MN, Kimura ET, Gandhi M,
Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G,
Fusco A, et al: BRAF mutations in thyroid tumors are restricted to
papillary carcinomas and anaplastic or poorly differentiated
carcinomas arising from papillary carcinomas. J Clin Endocrinol
Metab. 88:5399–5404. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim J, Giuliano AE, Turner RR, Gaffney RE,
Umetani N, Kitago M, Elashoff D and Hoon DS: Lymphatic mapping
establishes the role of BRAF gene mutation in papillary thyroid
carcinoma. Ann Surg. 244:799–804. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Costa AM, Herrero A, Fresno MF, Heymann J,
Alvarez JA, Cameselle-Teijeiro J and García-Rostán G: BRAF mutation
associated with other genetic events identifies a subset of
aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf).
68:618–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xing M, Westra WH, Tufano RP, Cohen Y,
Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, et
al: BRAF mutation predicts a poorer clinical prognosis for
papillary thyroid cancer. J Clin Endocrinol Metab. 90:6373–6379.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elisei R, Ugolini C, Viola D, Lupi C,
Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A and Basolo F:
BRAF(V600E) mutation and outcome of patients with papillary thyroid
carcinoma: A 15-year median follow-up study. J Clin Endocrinol
Metab. 93:3943–3949. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim DL, Song KH and Kim SK: High
prevalence of carcinoma in ultrasonography-guided fine needle
aspiration cytology of thyroid nodules. Endocr J. 55:135–142. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xing M, Tufano RP, Tufaro AP, Basaria S,
Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D and Ladenson
PW: Detection of BRAF mutation on fine needle aspiration biopsy
specimens: A new diagnostic tool for papillary thyroid cancer. J
Clin Endocrinol Metab. 89:2867–2872. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung KW, Yang SK, Lee GK, Kim EY, Kwon S,
Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, et al: Detection of BRAF
V600E mutation on fine needle aspiration specimens of thyroid
nodule refines cyto-pathology diagnosis, especially in BRAF600E
mutation-prevalent area. Clin Endocrinol (Oxf). 65:660–666. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kumagai A, Namba H, Akanov Z, Saenko VA,
Meirmanov S, Ohtsuru A, Yano H, Maeda S, Anami M, Hayashi T, et al:
Clinical implications of pre-operative rapid BRAF analysis for
papillary thyroid cancer. Endocr J. 54:399–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hwang J, Shin JH, Han BK, Ko EY, Kang SS,
Kim JW and Chung JH: Papillary thyroid carcinoma with BRAF V600E
mutation: Sonographic prediction. AJR Am J Roentgenol.
194:W425–W430. 2010. View Article : Google Scholar : PubMed/NCBI
|
